{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:16:04Z","timestamp":1793103364012,"version":"4.5.0"},"reference-count":138,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Novartis Gene Therapies, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2022,9,2]]},"DOI":"10.1080\/14712598.2022.2066471","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:19:52Z","timestamp":1650356392000},"page":"1075-1090","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":35,"title":["Onasemnogene abeparvovec for the treatment of spinal muscular atrophy"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-2018","authenticated-orcid":false,"given":"Hugh J.","family":"McMillan","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Neurology & Neurosurgery, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal M.","family":"Proud","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of the King\u2019s Daughters, Norfolk, VA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Farrar","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Sydney, NSW, Australia"},{"name":"Department of Neurology, Sydney Children\u2019s Hospital Network, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian E.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Gene Therapy Research Unit, Children\u2019s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children\u2019s Hospitals Network, Westmead, NSW, Australia"},{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[{"name":"The Dubowitz Neuromuscular Centre, University College London, Great Ormond Street Institute of Child Health London, UK"},{"name":"NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, & Great Ormond Street Hospital Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-4061","authenticated-orcid":false,"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre Hospitalier Universitaire de Li\u00e8ge & Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium"},{"name":"MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2020.11.009"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0671-8"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0724-z"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5020021"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2670"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.01.003"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.02.006"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007836"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7154-1"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2016.00007"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.004"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807305788"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1704732"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.09.007"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S172291"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.07.001"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200617"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190468"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27363"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.03.007"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01695-7"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7030033"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100742"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.15844\/pedneurbriefs-33-5"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.05.005"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.11.002"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.353"},{"key":"cit0030","unstructured":"Novartis Gene Therapies. Novartis Gene Therapies recommits to Global Managed Access Program for 2021. Novartis. 2021 Jan 15. Available at: www.novartis.com\/news\/novartis-gene-therapies-recommits-global-managed-access-program-2021 [Last accessed 2021 Jan 15]"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.11.007"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.681463"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.49"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-015-9899-5"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5448.2244"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01483-7"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.08.031"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz148"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00670"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658038"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05107-11"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.02.014"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00628-3"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.09.011"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.007"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00001-6"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.1272"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00251-9"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301514"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.726468"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.001"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.76"},{"key":"cit0055","unstructured":"ZOLGENSMA. Prescribing Information. Novartis; October 2021. Available at: www.novartis.us\/sites\/www.novartis.us\/files\/zolgensma.pdf [Last accessed 2021 Nov 8]"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(21)00287-X"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01356-1"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000741"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25101"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190403"},{"issue":"1","key":"cit0061","first-page":"S950","volume":"28","author":"Strauss K","year":"2021","journal-title":"Eur J Neurol"},{"key":"cit0062","volume-title":"Neurology","volume":"98","author":"Strauss KA","year":"2022"},{"key":"cit0063","unstructured":"SPR1NT: an open-label, single-arm clinical trial of presymptomatic patients with SMA. Novartis Gene Therapies, Inc. 2021. Available at: www.zolgensma-hcp.com\/clinical-experiences\/spr1nt-trial-efficacy. [Last accessed 2021 Nov 5]"},{"key":"cit0064","first-page":"76","volume":"450","author":"De Onis M","year":"2006","journal-title":"Acta Paediatr"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190451"},{"key":"cit0066","volume-title":"Neurology","volume":"98","author":"Servais L","year":"2022"},{"key":"cit0067","volume-title":"Neurology","volume":"98","author":"Servais L","year":"2022"},{"key":"cit0068","unstructured":"Registry of patients with a diagnosis of spinal muscular atrophy (SMA). ClinicalTrials.gov identifier: NCT04174157. 2019 Nov 22. Available at: clinicaltrials.gov\/ct2\/show\/NCT04174157?term=NCT04174157&draw=2&rank=1 [Last accessed 2021 Nov 5]"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxx125"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2020.111"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.07.287"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-0998-4"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200593"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0729"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.05.044"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.217"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.182"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02055-1"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2021.29182.bfs"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10020119"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007523"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.07.009"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.11.054"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01107-6"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51519"},{"key":"cit0086","volume-title":"Presented at: Virtual Workshop on Systemic Immunogenicity Considerations of AAV-Mediated Gene Therapy, NIH, NCATS","author":"Bonnemann CG","year":"2020"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005056"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00827-3"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152817"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119142"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.07.011"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2015.1088780"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2022.29198.bfs"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000228"},{"key":"cit0095","unstructured":"A study to evaluate the safety and tolerability of PF-06939926 gene therapy in Duchenne Muscular Dystrophy. ClinicalTrials.gov identifier: NCT03362502. 2021 Oct 15. Available at: clinicaltrials.gov\/ct2\/show\/NCT03362502. [Last accessed 2021 Dec 13]"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-020-00624-2"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200610"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2020.1843277"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.27.5.674"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2021.1889841"},{"key":"cit0101","unstructured":"Harris E. Potential solutions to current pricing models for cell and gene therapies. Horsham, PA: Life Science Leader, 2019 Oct 1. Available at: www.lifescienceleader.com\/doc\/potential-solutions-to-current-pricing-models-for-cell-and-gene-therapies-0001 [Last accessed 2021 Nov 5]"},{"key":"cit0102","unstructured":"Seymore B. Payment models for pricey transformative pharmaceuticals. PharmacyTimes.com. Updated 2020 Feb 4. Available at: https:\/\/www.pharmacytimes.com\/view\/payment-models-for-pricey-transformative-pharmaceuticals. [Last accessed 2021 Nov 5]"},{"key":"cit0103","unstructured":"Wong CH, Li D, Wang N, et al. Estimating the financial impact of gene therapy. medRxiv. Available at: www.medrxiv.org\/content\/10.1101\/2020.10.27.20220871v1.full [Last accessed 2021 Nov 8]"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2020.1822666"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.09.021"},{"key":"cit0106","unstructured":"Jena AB, Lakdawalla DN. Value frameworks for rare diseases: should they be different? Washington, DC: Health Affairs Blog, 2017 Apr 12. Available at: www.healthaffairs.org\/do\/10.1377\/hblog20170412.059563\/full\/ [Last accessed 2021 Apr 12]."},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.01.008"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-326344"},{"key":"cit0109","unstructured":"Safety and efficacy of intravenous OAV101 (AVXS-101) in pediatric patients with spinal muscular atrophy (SMA) (SMART). clinicalTrials.gov identifier: NCT04851873. 2021 Apr 21. Available at: clinicaltrials.gov\/ct2\/show\/NCT04851873 [Last accessed 2021 Nov 5]"},{"key":"cit0110","unstructured":"Study of intrathecal administration of onasemnogene abeparvovec-xioi for spinal muscular atrophy (STRONG). ClinicalTrials.gov identifier: NCT03381729. 2021 June 9. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03381729?term=NCT03381729 [Last accessed 2021 Nov 18]"},{"key":"cit0111","volume-title":"Presented online at the 16th International Child Neurology Congress\/49th International Child Neurology Society 2020 Virtual Annual Meeting","author":"Finkel RS"},{"key":"cit0112","unstructured":"Efficacy and safety of intrathecal OAV101 (AVXS-101) in pediatric patients with type 2 spinal muscular atrophy (SMA) (STEER). ClinicalTrials.gov identifier: NCT05089656. 2021 Oct 22. Available at: clinicaltrials.gov\/ct2\/show\/NCT05089656. [Last accessed 2021 Nov 5]"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27034"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105488"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14935"},{"issue":"2","key":"cit0116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/jnc.14974","volume":"153","author":"Poletti A","year":"2020","journal-title":"J Neurochem"},{"key":"cit0117","unstructured":"A study of nusinersen among participants with spinal muscular atrophy who received onasemnogene abeparvovec (RESPOND). ClinicalTrials.gov identifier: NCT04488133. 2021 Sept 29. Available at: www.clinicaltrials.gov\/ct2\/show\/NCT04488133 [Last accessed 2021 Oct 20]"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14798"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.06.012"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.747726"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-020-00630-2"},{"key":"cit0122","first-page":"366","volume":"20","author":"Nonnenmacher M","year":"2021","journal-title":"Mol Ther"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.41"},{"key":"cit0124","first-page":"5432","volume":"11","author":"Weinmann J","year":"2020","journal-title":"Nature"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.08.028"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-019-0673-0"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15117"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9139-6_7"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwz131"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.255"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1007\/s40778-016-0037-5"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.08.031"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.3390\/genes11080921"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200127"},{"key":"cit0136","unstructured":"U.S. National Library of Medicine. ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=crispr&cntry=&state=&city=&dist= [Last accessed 2022 Mar 10]"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00898"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1904889"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2022.2066471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:49:14Z","timestamp":1672811354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2022.2066471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":138,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,2]]}},"alternative-id":["10.1080\/14712598.2022.2066471"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2022.2066471","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}